Paper38360641
Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look.
Abbasi-Malati Z and 7 others. Cell Commun Signal, 2024. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look. Papers, record 38360641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38360641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Exosomes | Major topic |
| Neoplasms | Major topic |
| Extracellular Vesicles | Major topic |
| Humans | |
| Carcinogenesis | |
| Signal Transduction | |
| Tumor Microenvironment |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 71399 | Tabriz University of Medical Sciences | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06871904 | Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis | Background |
Source ClinicalTrials.gov
References295
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25320245 | Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. | Blood | 2014 | https://conductscience.org/library/papers/25320245 | PubMed |
| 2 | 32269736 | Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasis. | Am J Transl Res | 2020 | https://conductscience.org/library/papers/32269736 | PubMed |
| 3 | 33330451 | Exosomal miRNA-16-5p Derived From M1 Macrophages Enhances T Cell-Dependent Immune Response by Regulating PD-L1 in Gastric Cancer. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/33330451 | PubMed |
| 4 | 35158768 | Exosomes in Cancer Therapy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35158768 | PubMed |
| 5 | 36932387 | Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. | Mol Cancer | 2023 | https://conductscience.org/library/papers/36932387 | PubMed |
| 6 | 34093824 | Tumor-derived Exosome Promotes Metastasis via Altering its Phenotype and Inclusions. | J Cancer | 2021 | https://conductscience.org/library/papers/34093824 | PubMed |
| 7 | 34292880 | Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1. | Aging (Albany NY) | 2021 | https://conductscience.org/library/papers/34292880 | PubMed |
| 8 | 34717769 | Mesenchymal stem cells-derived exosomes for drug delivery. | Stem Cell Res Ther | 2021 | https://conductscience.org/library/papers/34717769 | PubMed |
| 9 | 33253966 | Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. | Biomaterials | 2021 | https://conductscience.org/library/papers/33253966 | PubMed |
| 10 | 34560422 | M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages. | Biomaterials | 2021 | https://conductscience.org/library/papers/34560422 | PubMed |
| 11 | 35071216 | Review on Strategies and Technologies for Exosome Isolation and Purification. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/35071216 | PubMed |
| 12 | 36430452 | Harnessing Normal and Engineered Mesenchymal Stem Cells Derived Exosomes for Cancer Therapy: Opportunity and Challenges. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430452 | PubMed |
| 13 | 35700679 | Recent progress of dendritic cell-derived exosomes (Dex) as an anti-cancer nanovaccine. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35700679 | PubMed |
| 14 | 32268136 | Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment. | Exp Cell Res | 2020 | https://conductscience.org/library/papers/32268136 | PubMed |
| 15 | 31951852 | lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer. | Mol Ther Nucleic Acids | 2020 | https://conductscience.org/library/papers/31951852 | PubMed |
| 16 | 33061571 | Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt/β-Catenin Signaling. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33061571 | PubMed |
| 17 | 36093435 | Exosomal lncRNA PCAT1 Promotes Tumor Circulating Cell-Mediated Colorectal Cancer Liver Metastasis by Regulating the Activity of the miR-329-3p/Netrin-1-CD146 Complex. | J Immunol Res | 2022 | https://conductscience.org/library/papers/36093435 | PubMed |
| 18 | 35722996 | CAFs-derived small extracellular vesicles circN4BP2L2 promotes proliferation and metastasis of colorectal cancer via miR-664b-3p/HMGB3 pathway. | Cancer Biol Ther | 2022 | https://conductscience.org/library/papers/35722996 | PubMed |
| 19 | 33738282 | Could Extracellular Vesicles Contribute to Generation or Awakening of "Sleepy" Metastatic Niches? | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/33738282 | PubMed |
| 20 | 33823894 | Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33823894 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42016928 | Transforming Duchenne muscular dystrophy therapy: The multifaceted role of extracellular vesicles and exosomes. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/42016928 | PubMed |
| 42010708 | Application of dendritic cell extracellular vesicles as a valid nanoparticle platform for cancer therapies: a narrative review. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42010708 | PubMed |
| 41867505 | Regenerative strategies for post-prostatectomy incontinence: stem cells, exosomes, and the path to clinical resolution. | Am J Clin Exp Urol | 2026 | https://conductscience.org/library/papers/41867505 | PubMed |
| 41514320 | Microvesicles, exosomes and their combinations with cytoplasmic organelles: from their discovery to their innovative roles in clinical medicine. | Biol Direct | 2026 | https://conductscience.org/library/papers/41514320 | PubMed |
| 41322395 | Autophagy stimulation influenced the angiogenesis and metastasis behavior of human triple-negative breast cancer cells. | Bioimpacts | 2025 | https://conductscience.org/library/papers/41322395 | PubMed |
| 40922748 | Hypoxic exosomes alleviated the spinal cord injury after ischemic/reperfusion in a rat model. | Adv Pharm Bull | 2025 | https://conductscience.org/library/papers/40922748 | PubMed |
| 40598419 | Peritoneal cavity-derived small extracellular vesicles from aged tumor-naïve hosts promote ovarian cancer adhesion and invasion. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40598419 | PubMed |
| 40452185 | Cancer-derived extracellular vesicles in natural killer cell immune evasion: Molecular mechanisms and therapeutic insights. | Mol Ther | 2025 | https://conductscience.org/library/papers/40452185 | PubMed |
| 40272656 | Modeling of cancer stem cells and the tumor microenvironment Via NT2/D1 cells to probe pathology and treatment for cancer and beyond. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40272656 | PubMed |
| 40256240 | Role of Toll-like receptors in exosome biogenesis and angiogenesis capacity. | Bioimpacts | 2025 | https://conductscience.org/library/papers/40256240 | PubMed |
| 40100465 | Exosomes derived from natural killer cells: transforming immunotherapy for aggressive breast cancer. | Med Oncol | 2025 | https://conductscience.org/library/papers/40100465 | PubMed |
| 39696346 | Exosomes and breast cancer angiogenesis; Highlights in intercellular communication. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39696346 | PubMed |
| 38943222 | Therapeutic potential of extracellular vesicles from diverse sources in cancer treatment. | Eur J Med Res | 2024 | https://conductscience.org/library/papers/38943222 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38360641
GET https://conductscience.org/api/papers/v1/38360641/references?page=2